- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Liothyronine
Liothyronine (liothyronine sodium) is a synthetic form of triiodothyronine (T3), a naturally occurring thyroid hormone. It is indicated for the treatment of hypothyroidism, including myxedema coma and myxedema, as an adjunct to surgery and radioiodine therapy in the management of thyroid cancer, and for the diagnostic use in the T3 suppression test. Liothyronine works by binding to nuclear thyroid hormone receptors, increasing basal metabolic rate, stimulating oxygen consumption, and affecting protein, carbohydrate, and lipid metabolism. It has a more rapid onset and shorter duration of action than levothyroxine (T4), making it useful in situations requiring quick thyroid hormone replacement or withdrawal. Liothyronine is available only by prescription in Canada.
Usual adult dose: The dosage is individualized based on patient response, age, and cardiovascular status. For mild hypothyroidism, the recommended starting dose is 25 mcg taken orally once daily. For severe, long-standing hypothyroidism, the initial dose should be lower, such as 5 mcg to 10 mcg once daily, increased gradually by 5 mcg to 10 mcg increments at intervals of 1 to 2 weeks. The usual maintenance dose ranges from 25 mcg to 75 mcg per day, given once daily or in divided doses. The 20 mcg tablet is an alternative strength used for fine dose adjustments. For myxedema coma, an intravenous form is used initially; oral liothyronine is not appropriate for emergency treatment. In elderly patients or those with cardiovascular disease, the starting dose should be 5 mcg daily and titrated slowly. Liothyronine should be taken at the same time each day, preferably on an empty stomach, at least 30 minutes before breakfast. If a dose is missed, it should be taken as soon as remembered, but two doses should not be taken at the same time. The dose may need to be reduced in patients with adrenal insufficiency or when switching from levothyroxine.
Dosage form: Oral tablets: 20 mcg (white, round, scored) and 25 mcg (white, round, scored). Also available as an injectable solution for intravenous use. The 20 mcg and 25 mcg strengths allow for precise dose titration in patients requiring lower or incremental dosing.
Onset of action: The onset of action is rapid compared with levothyroxine; clinical effects may be seen within 2 to 4 hours after oral administration, with peak metabolic activity at 2 to 3 days. Improvement in symptoms of hypothyroidism may begin within 1 to 2 weeks of starting therapy.
Duration of action: The half-life of liothyronine is approximately 1 to 2 days, and the duration of clinical effect is about 24 to 72 hours, supporting once-daily or twice-daily dosing. Because of its short half-life, serum T3 levels fluctuate more than with levothyroxine; divided dosing may be used to achieve more stable levels.
Alcohol recommendation: No direct interaction between liothyronine and alcohol has been established. However, alcohol may affect thyroid function and liver metabolism, potentially altering the effectiveness of the medication. Patients should limit alcohol intake and discuss any significant consumption with their healthcare professional.
Most common side effects: The most common adverse effects are symptoms of hyperthyroidism due to excessive dosing, including palpitations, tachycardia, arrhythmias, weight loss, nervousness, tremors, insomnia, sweating, heat intolerance, and diarrhea. Chest pain, dyspnea, and exacerbation of angina may occur in patients with coronary artery disease. Chronic overtreatment can lead to bone loss and atrial fibrillation. Liothyronine is contraindicated in patients with untreated thyrotoxicosis, uncorrected adrenal insufficiency, or acute myocardial infarction. It should be used with caution in patients with cardiovascular disease, diabetes mellitus, and in the elderly. Thyroid function tests (TSH, free T3, free T4) should be monitored regularly, and the dose adjusted accordingly. Liothyronine is available only by prescription in Canada and must be prescribed and monitored by a healthcare professional experienced in thyroid disorders.
Would you like to try Liothyronine without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
